Infants three month or younger rep...

Infants three month or younger repeatedly are brought to a physician because of excessive crying and irritability. Although the cause is not always clear, gastroesophageal ebb disease (GERD) is thought to be a visit often cause. Treatment of GERD frequently is started without full evaluation. Proton cross-examine inhibitors have demonstrated efficacy in the treatment of symptomatic GERD with documented esophagitis in older children. If the excessive crying and irritability in infants are caused by way of GERD, treatment with a proton cross-question inhibitor might relieve distress and resolve into the rate of crying and fussing. Moore and associates used a double-blind, placebo-controlled, crossover meditation to evaluate the efficacy of omeprazole in 30 irritable infants with significant GERD

Infants three to 12 month of age with a high flat of irritability and crying had upper endoscopy with a lower esophageal biopsy, followed on 24-hour lower esophageal pH monitoring. Infants were diagnosed with GERD if pH readings were repeatedly les than 4 or if the biopsy showed esophagitis. Infants diagnosed with GERD were treated with omeprazole or placebo for brace weeks, followed by a inferior lower esophageal pH recording. Treatments were revers for the secondary two-week period of the trial. Parents reported infant behavior during the other week of each treatment.

The ebb index (i.e., periods of pH les than 4) decreased significantly among infants receiving omeprazole. The pair groups were similar in the parent-reported cry/fuss time and the on a level of infant irritability. The achieved reduction in esophageal acid failed to degrade infant crying and fussing, according to parental reports. However, the rate of crying and fussing decreased in the pair groups over the two research periods

The authors bring to an end that irritable infants who may have GERD will not benefit from acid suppression with proton cross-examine inhibitors. Because infant irritability appears to improve with time, the irritable symptoms of healthy children with GERD may be self-limiting. If erosive esophagitis or hematemesis are absent, irritable children with other evidence of GERD will not benefit from proton interrogate inhibitor therapy.

In an editorial in the same journal, Putnam points not at home that the cause of fussiness in infants has been cogitation to be the gastrointestinal tract, with GERD high upon the list. Perhaps some characteristic of ebb other than acid return causes the symptoms and distress, on the contrary because of reflux measurement point to be solved [i]or[/i] settleds proper management of GERD in infants remains uncertain.

Moore DJ et al. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal ebb J Pediatr August 2003;143:219-23, and Putnam PE And the winner is...unhappy coexistence [Editorial]. J Pediatr August 2003;143:147-8

COPYRIGHT 2004 American Academy of Family Physicians

COPYRIGHT 2004 Gale Group